SELLAS Life Sciences (SLS) Capital Expenditures (QoQ) (2010 - 2016)
SELLAS Life Sciences (SLS) Capital Expenditures (QoQ) (2010 - 2016) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | SELLAS Life Sciences | 3.23 Mn | 3.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | -98.68% |
| Dec 31, 2015 | 863.83% |
| Sep 30, 2015 | 110.09% |
| Jun 30, 2015 | -193.20% |
| Mar 31, 2015 | 5,455.56% |
| Dec 31, 2014 | -52.63% |
| Sep 30, 2014 | 171.43% |
| Jun 30, 2014 | -68.18% |
| Mar 31, 2014 | 109.40% |
| Dec 31, 2013 | -325.00% |
| Jun 30, 2011 | -67.50% |
| Mar 31, 2011 | -2.44% |
| Dec 31, 2010 | 272.73% |